143 related articles for article (PubMed ID: 32631380)
21. Texture analysis on the fluence map to evaluate the degree of modulation for volumetric modulated arc therapy.
Park SY; Kim IH; Ye SJ; Carlson J; Park JM
Med Phys; 2014 Nov; 41(11):111718. PubMed ID: 25370632
[TBL] [Abstract][Full Text] [Related]
22. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
[TBL] [Abstract][Full Text] [Related]
23. Moving from gamma passing rates to patient DVH-based QA metrics in pretreatment dose QA.
Zhen H; Nelms BE; Tome WA
Med Phys; 2011 Oct; 38(10):5477-89. PubMed ID: 21992366
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
25. An algorithm to calculate a collapsed arc dose matrix in volumetric modulated arc therapy.
Arumugam S; Xing A; Jameson M; Holloway L
Med Phys; 2013 Jul; 40(7):071724. PubMed ID: 23822428
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
27. Comparison of DVH-based plan verification methods for VMAT: ArcCHECK-3DVH system and dynalog-based dose reconstruction.
Saito M; Kadoya N; Sato K; Ito K; Dobashi S; Takeda K; Onishi H; Jingu K
J Appl Clin Med Phys; 2017 Jul; 18(4):206-214. PubMed ID: 28649722
[TBL] [Abstract][Full Text] [Related]
28. Treatment planning for radiotherapy with very high-energy electron beams and comparison of VHEE and VMAT plans.
Bazalova-Carter M; Qu B; Palma B; Hårdemark B; Hynning E; Jensen C; Maxim PG; Loo BW
Med Phys; 2015 May; 42(5):2615-25. PubMed ID: 25979053
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric comparison of three-dimensional conformal radiotherapy versus volumetric-arc radiotherapy in cervical cancer treatment: applying the central-shielding principle to modern technology.
Tamaki T; Hirai R; Igari M; Kumazaki Y; Noda SE; Suzuki Y; Kato S
J Radiat Res; 2018 Sep; 59(5):639-648. PubMed ID: 30053184
[TBL] [Abstract][Full Text] [Related]
30. Modulation index for VMAT considering both mechanical and dose calculation uncertainties.
Park JM; Park SY; Kim H
Phys Med Biol; 2015 Sep; 60(18):7101-25. PubMed ID: 26317697
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
Du XX; Yang H; Zhang HJ; Li LA; Fan WS; Meng YG
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):679-686. PubMed ID: 29060966
[No Abstract] [Full Text] [Related]
32. Monte Carlo dose verification of VMAT treatment plans using Elekta Agility 160-leaf MLC.
Onizuka R; Araki F; Ohno T
Phys Med; 2018 Jul; 51():22-31. PubMed ID: 30278982
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification.
McDermott LN; Wendling M; van Asselen B; Stroom J; Sonke JJ; van Herk M; Mijnheer BJ
Med Phys; 2006 Oct; 33(10):3921-30. PubMed ID: 17089854
[TBL] [Abstract][Full Text] [Related]
34. Comparison between two treatment planning systems for volumetric modulated arc therapy optimization for prostate cancer.
Lafond C; Gassa F; Odin C; Dréan G; Even J; De Crevoisier R; Pommier P; Manens JP; Biston MC
Phys Med; 2014 Feb; 30(1):2-9. PubMed ID: 23116552
[TBL] [Abstract][Full Text] [Related]
35. Dose prediction for cervical cancer VMAT patients with a full-scale 3D-cGAN-based model and the comparison of different input data on the prediction results.
Zhang G; Jiang Z; Zhu J; Wang L
Radiat Oncol; 2022 Nov; 17(1):179. PubMed ID: 36372897
[No Abstract] [Full Text] [Related]
36. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
[No Abstract] [Full Text] [Related]
37. Integration of radiobiological modeling and indices in comparative plan evaluation: A study comparing VMAT and 3D-CRT in patients with NSCLC.
Roy S; Badragan I; Ahmed SN; Sia M; Singh J; Bahl G
Pract Radiat Oncol; 2018; 8(5):e355-e363. PubMed ID: 29703705
[TBL] [Abstract][Full Text] [Related]
38. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
39. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
[TBL] [Abstract][Full Text] [Related]
40. An in vivo dose verification method for SBRT-VMAT delivery using the EPID.
McCowan PM; Van Uytven E; Van Beek T; Asuni G; McCurdy BM
Med Phys; 2015 Dec; 42(12):6955-63. PubMed ID: 26632051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
